Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aliki Xochelli

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Nature Medicine|July 17, 2023
SARS-CoV-2-specific T cell therapy for severe COVID-19: a randomized phase 1/2 trialAnastasia Papadopoulou, George Karavalakis, Efthymia Papadopoulou, et al.
Blood|January 4, 2019
Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impactPanagiotis Baliakas, Sabine Jeromin, Michalis Iskas, et al.
The Journal of Pathology|November 29, 2018
Disease-biased and shared characteristics of the immunoglobulin gene repertoires in marginal zone B cell lymphoproliferationsAliki Xochelli, Vasilis Bikos, Eleftheria Polychronidou, et al.
Blood Advances|May 27, 2026
Integrated multi-omic profiling reveals two distinct splenic marginal zone lymphoma subgroups with prognostic relevanceHelen Parker, Amatta Mirandari, Ben Stevens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 25, 2017
Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical OutcomesAliki Xochelli, Panagiotis Baliakas, Ioannis Kavakiotis, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Nature Medicine|July 17, 2023
SARS-CoV-2-specific T cell therapy for severe COVID-19: a randomized phase 1/2 trialAnastasia Papadopoulou, George Karavalakis, Efthymia Papadopoulou, et al.
Blood|January 4, 2019
Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impactPanagiotis Baliakas, Sabine Jeromin, Michalis Iskas, et al.
The Journal of Pathology|November 29, 2018
Disease-biased and shared characteristics of the immunoglobulin gene repertoires in marginal zone B cell lymphoproliferationsAliki Xochelli, Vasilis Bikos, Eleftheria Polychronidou, et al.
Blood Advances|May 27, 2026
Integrated multi-omic profiling reveals two distinct splenic marginal zone lymphoma subgroups with prognostic relevanceHelen Parker, Amatta Mirandari, Ben Stevens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 25, 2017
Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical OutcomesAliki Xochelli, Panagiotis Baliakas, Ioannis Kavakiotis, et al.
Pageof 6